Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells
CONCLUSION: Our findings point to nAChRs as responsible for the decrease in the chemotherapeutic effect of paclitaxel in triple negative tumors. Thus, nAChRs should be considered as targets in smoking patients.PMID:35949430 | PMC:PMC9244968 | DOI:10.5306/wjco.v13.i6.505
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Alejandro Espa ñol Yamila Sanchez Agustina Salem Jaqueline Obregon Maria Elena Sales Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | International Medicine & Public Health | Nicotine | Smokers